Attenuation of HIV-1 Infectivity by an Inhibitor of Oligosaccharide Processing
Authors:
- Nancy Vander HeydenNHNancy Vander Heyden
- Lee RatnerLRLee Ratner
- 1 June 1990
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 6 (6) , 785-794
Abstract
A series of inhibitors of trimming glucosidases and mannosidases were examined for antiviral activity toward HIV-1. N -butyl deoxynojirimycin ( N -buDNJ) was found to be the most potent agent studied. Treatment of acutely infected lymphoid cells with 2.0 m M N -buDNJ reduced virus yield more than 90%, without affecting cell growth. Though lower concentrations of N-buDNJ (0.002-0.2 mM) did not affect HIV-1 production, there was complete inhibition of syncytia formation. Treatment of chronically infected lymphoid cells with 0.1-1.0 m M N -buDNJ resulted in no significant change in virus production, but 80% reduction of infectivity. The attenuation in HIV-1 infectivity was due at least partially to diminished binding to CD4 + lymphoid cells. Chronically infected lymphoid cells treated with 0.02-1.0 m M N -buDNJ for at least 3 days were markedly impaired in their ability to form syncytia with uninfected lymphoid cells. N -buDNJ treatment of HIV-1 infected cells resulted in both a reduction in the cell surface envelope proteins, and an increase in their apparent molecular weight. These results show that N -buDNJ can be used to impair the infectivity of HIV-1 without significant toxicity.Keywords
This publication has 4 references indexed in Scilit:
- Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirusJournal of Virology, 1989
- In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivityJournal of Virology, 1988
- The role of envelope glycoprotein processing in murine leukemia virus infectionJournal of Virology, 1987
- Carbohydrate side chains of Rauscher leukemia virus envelope glycoproteins are not required to elicit a neutralizing antibody responseJournal of Virology, 1986